Titin-related myopathies are heterogeneous clinical conditions associated with mutations in TTN. To define their histopathologic boundaries and try to overcome the difficulty in assessing the pathogenic role of TTN variants, we performed a thorough morphological skeletal muscle analysis including light and electron microscopy in 23 patients with different clinical phenotypes presenting pathogenic autosomal dominant or autosomal recessive (AR) mutations located in different TTN domains. We identified a consistent pattern characterized by diverse defects in oxidative staining with prominent nuclear internalization in congenital phenotypes (AR-CM) (n ¼ 10), 6 necrotic/regenerative fibers, associated with endomysial fibrosis and rimmed vacuoles (RVs) in AR early-onset Emery-Dreifuss-like (AR-ED) (n ¼ 4) and AR adult-onset distal myopathies (n ¼ 4), and cytoplasmic bodies (CBs) as predominant finding in hereditary myopathy with early respiratory failure (HMERF) patients (n ¼ 5). Ultrastructurally, the most significant abnormalities, particularly in AR-CM, were multiple narrow core lesions and/or clear small areas of disorganizations affecting one or a few sarcomeres with M-band and sometimes A-band disruption and loss of thick filaments. CBs were noted in some AR-CM and associated with RVs in HMERF and some AR-ED cases. As a whole, we described recognizable histopathological patterns and structural alterations that could point toward considering the pathogenicity of TTN mutations.
INTRODUCTION
Titin is the largest human protein (33 000 amino acids) (1, 2) and is encoded by the TTN gene (OMIM *188840) on chromosome 2q31 (3) (4) (5) . Titin is expressed in both skeletal and cardiac muscles (6) (7) (8) and is located in the sarcomere extending from the Z-disc to the M-line (9) . Its amino-terminal domain is anchored to the Z-disc interacting with many proteins at this level (10) (11) (12) . The I-band region is responsible of the elastic property of the protein (13, 14) whereas the A-band region represents the largest part of the protein and is a rigid portion tightly associated to myosin, providing stabilization to the sarcomere (5) . The carboxy-terminal domain contains a kinase domain. At this level, titin filaments from the adjacent half-sarcomere overlap and connect with other protein elements such as myomesin (15) and calpain 3 (16) . Titin has a critical role in the maintenance of the sarcomere structure during the contraction (17) (18) (19) .
Next generation sequencing (NGS) approaches have led to an exponential increase in the number of identified mutations, either pathogenic mutations or changes of unknown significance, in TTN. To date, mostly through NGS methods, TTN mutations have been associated with a large spectrum of clinical conditions ranging from isolated dilated or hypertrophic cardiomyopathies (MIM #604145; MIM #613765) (20) (21) (22) (23) to numerous skeletal muscle myopathies (MIM #600334, MIM #608807, MIM #603689, MIM #611705) (24) (25) (26) . However, not all rare TTN variants are associated with a disease and in this respect a recent study by Savarese et al highlighted how challenging is the assignment of new mutations to a plausible titinopathy (27) and that, in all likelihood, new phenotypes may emerge in the future. For this reason, histopathological phenotype and genotype correlations are of critical importance, particularly because functional studies are possible only for some mutations located in specific TTN domains (28) .
Histopathological changes in TTN-related myopathies are markedly variable as reported in muscle biopsies from patients with tibial muscular dystrophy ([TMD]; MIM #600334) and limb-girdle muscular dystrophy 2J ([LGMD2J]; MIM #608807) with rimmed vacuoles (RVs) (29, 30) , or hereditary myopathy with early respiratory failure ([HMERF]; MIM #603689) with cytoplasmic bodies (CBs) (31) (32) (33) (34) (35) . Moreover, increased nuclear internalization and deficits in oxidative staining described as minicores/minicore-like lesions have been reported in early-onset myopathies (28, 36, 37) . Nevertheless, to date, a systematic and exhaustive skeletal muscle histopathologic and ultrastructural analysis have not been performed in large cohorts of TTN-related conditions.
In order to define histopathologic boundaries of TTNrelated myopathies and help both clinicians and geneticists supporting the pathogenic role of TTN variants, we report a systematic histopathological and ultrastructural analysis of 23 patients with TTN mutations presenting different clinical phenotypes.
MATERIALS AND METHODS

Patients
Twenty-three patients (14 male and 9 female) of various ethnic backgrounds were included in the present study. Patients P1 to P10, P14, and P17 to P20 (n ¼ 15) are reported herein for the first time. Part of the clinical, pathologic or genetic data from patients P11 to P13, P15, P16, and P21 to P23 (n ¼ 8) have been previously reported (35, (38) (39) (40) (41) . Clinical data of these patients were systematically retrieved and retrospectively analyzed (Table 1) . Patients were classified into 4 groups according to their clinical features as follows: Group 1: Autosomal recessive congenital myopathy (AR-CM) (n ¼ 10); Group 2: Autosomal recessive early-onset Emery-Dreifusslike myopathy without associated cardiomyopathy (AR-ED) (n ¼ 4); Group 3: Autosomal recessive young or early-adult onset distal myopathy (AR-DM) (n ¼ 4); and Group 4: HMERF (n ¼ 5). All patients underwent open biopsy for morphological and histochemical analyses of fresh-frozen skeletal muscle tissue.
Mutation Analysis
Patients or parents gave informed consent for the genetic analysis and DNA storage according to French legislation (Comit e de Protection des Personnes Est IV DC-2012-1693). Genomic DNA was extracted from blood or frozen skeletal muscle by standard methods. DNA was studied by direct sequencing of exons of TTN gene or exome sequencing. Exome sequencing was performed for patients P1, P2, P3, P4, P5, P7, P8, P9, P10, P17, P18, and P19 with the SureSelect Human All Exon 50 Mb Capture Library v5, P6 and P14 with SureSelect Human All Exon Capture Library v6 (Agilent, Santa Clara, CA) and paired-end sequenced on a HiSeq 2500 (Illumina, San Diego, CA). Confirmation of variants and segregation was performed by Sanger sequencing of genomic DNA and cDNA (Transcript variant IC, References Sequences NM_001267550.2), with standard techniques. P20 mutations were determined by Sanger sequencing. Sequencing primers are available on request. PCR was performed with DreamTaq DNA polymerase according to standard protocol (Fermentas, Waltham, MA). PCR products were sequenced on an ABI3730xl DNA Analyzer (Applied Biosystems, Foster City, CA), using the Big-Dye Terminator v3.1 kit and analyzed with Sequencher 5.0 software (Gene Codes Corp., Ann Arbor, MI).
Morphological Studies
Open muscle biopsy was performed for all patients after informed consent. Age at biopsy varied from 1 month (P9) to 71 years (P20). The biopsied muscle is reported in Table 2 Detailed EM analysis was performed in 19 patients (Table 2) . For ultrastructural studies, small muscle samples were fixed in 2.5% glutaraldehyde, pH 7.4, postfixed in 2% osmium tetroxide for 2 hours, dehydrated and embedded in epoxy resin. At least 3 blocks from each patient were studied, including longitudinal and transverse-oriented samples. Semithin sections were stained by toluidine blue and examined in light microscopy to select pathological areas. Ultrathin sections were stained with uranyl acetate and lead citrate. The grids were observed using a Philips CM120 electron microscope (80 kV; Philips Electronics NV, Eindhoven, The Netherlands).
RESULTS
Clinical Findings
Clinical summary and laboratory features of all patients are provided in Table 1 .
Group 1: AR-CM patients, P1-P10, showed congenital hypotonia or early onset diffuse muscle weakness, with congenital arthrogryposis or early development of contractures (P8, P9, and P10); associated cardiomyopathy was found in P7 and P8.
Group 2: AR-ED patients, P11-P13 have been recently reported (38) and P14 is firstly described in this report.
Group 3: AR-DM patients, P15-P18, showed distal or proximal-distal early severe muscle weakness of the 4 limbs. P15 and P16 were described elsewhere (39, 41) . P17 and P18 are reported here for the first time.
Group 4: HMERF group included patients P19-P23. Most of them had adult onset weakness with diaphragmatic respiratory failure. Earlier onset (10 years) has been observed in P19. Patients P21-P23 were previously reported (35) .
Molecular Data
To identify the mutations in patients without a genetic diagnosis, we performed exome sequencing on genomic DNA from the patients and their parents. Exome sequencing allows a fast and parallel screening of most human genes, and is suitable and efficient for the diagnosis of neuromuscular diseases and the analysis of large genes such as TTN (42) . This approach also covers any newly discovered gene for the disorder.
For all patients, we found known or novel mutations in TTN (Table 1) . These changes were confirmed by Sanger sequencing, and their familial segregation validated when parental DNA was available. Parents of patients P1, P2, P3, P4, P5, P7, P8, P9, P10, P11, P12, P13, P14, P17, and P18 were screened to confirm the segregation of the mutations and to verify that TTN mutations are on opposite alleles (in trans position). Most of the patients harbored compound heterozygous mutations (21 patients), at least one of them was a truncating mutation (frameshift, nonsense mutation or mutation affecting an essential splice site) leading to a predicted protein truncation or degradation ( Table 1 ). The second mutations were either truncating mutations or rare missense mutations. Two cases carried homozygous mutations: P11 (AR-ED) and P22 (HMERF). Several mutations were previously known or affected exons already mutated in the disease. The mutations were located in different protein domains (Table 1) .
Patients from Group 1 (AR-CM) had the most heterogeneous results. Although variants were distributed all along the protein, they mostly were located within the A-band (9 of 10 cases). I-band was involved in 3 of 10 cases, and both M-line and Z-line in 2 of 10 cases, respectively. As recently reported, patients P11-P13 from Group 2 (AR-ED) had TTN mutations located in exons coding for the M-line domain 
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Titinopathies: Ultrastructural Particularities (Mex1-Mex3) (38) . P14 showed a similar phenotype with severe proximal weakness mainly in lower limbs and limitation in abduction of the arms due to mild contracture of the shoulder, but mutations were located in exons 363/Mex5 and 94 (I-band). In Group 3 (AR-DM), a combination of Mex5/Mex6 mutations and a second mutation involving A-band domain was present in all patients (39) (40) (41) . Finally, HMERF patients carried several reported mutations in exon 344 (35) . We studied Calpaine 3 on Western blot in 5 patients (P6, P11, P12, P13, and P14). Four patients (P11, P12, P13, and P14) harboring at least one mutation in different TTN exons coding for M-line domain (Mex) had calpain deficiency without mutations in CAPN3.
Morphological Findings
Detailed histopathologic analysis is reported in Table 2 . Group 1: AR-CM (P1-P10) ( Figs. 1 and 2 ). Muscle biopsies from all cases showed multiple small irregular and randomly distributed areas of reduced/absent oxidative activity or better-defined core areas (P1, P2, P3, P7) associated with mild fiber size variability, type 1 fiber predominance and increased nuclear internalizations (Fig. 1A-F ). Increased frequency of nuclear centralizations was evident in 4 cases (P2, P3, P7, P8). In addition, P9 and P10 displayed numerous CBs in atrophic fibers. Using EM, we identified variable length sarcomere disorganizations characterized by (i) clear small areas of M-line dissolution by subsequent disintegration of thick filaments, running along one or a few sarcomeres with preservation of the Z-line structure (P1, P3, P7, P9) ( Fig. 2A, B) ; some areas of myofibrillar disorganization extended through the adjacent myofibrils; (ii) focal areas of diffusion of Z-line material resembling small "pennants" starting from the Z-line (P4, P5, P6, P7, P8) (Fig. 2C, D) ; sometimes, the electron dense material appeared to span the full width of a sarcomere (Fig. 2F) ; (iii) many focal areas of sarcomeric disruption affecting a few sarcomeres with Z-line streaming and sharp limits from the adjoining normal sarcomeres with paucity of mitochondria, evoking classical minicores (P1, P2, P3, P4, P6, P7, P9) (Fig. 2E) . Moreover, P9 and P10 showed additional changes as CBs (P9, P10), nuclear inclusions corresponding to tubulofilamentous aggregates (P10), duplication of triads (P10) or atrophic fibers showing disorganized internal structure with thin filaments and small segments of dense Z material (P9, P10). Internalized/centralized nuclei were common in most of the cases. Group 2: AR-ED (P11-P14) (Figs. 3A-C, 4) . Muscle biopsies showed a dystrophic pattern with marked fiber size variability, necrotic and regenerative fibers, endomysial fibrosis, numerous RVs and sometimes rods or CBs (Fig. 3A-C) . In addition, irregularities in oxidative staining were also evident in most of the cases. Ultrastructural study showed also the presence of clear small and focal areas of sarcomere M-line dissolution spanning one or a few sarcomeres with almost complete preservation of the Z-line (P11, P12) (Fig. 4A, B) , and dense Z-line material disrupted (Fig. 4C) , or resembling small "pennants" (P13, P14). CBs were observed in P12 and P13; some of them showed small segments of dense material among the thin filaments in the peripheral halo. Moreover, nemaline bodies (P12, P13, P14) with the characteristic square lattice structure (Fig. 4D) , RVs containing degradation products (P13, P14), tubulofilamentous sarcoplasmic (P13) and nuclear inclusions (P12, P13) were also observed.
Group 3: AR-DM (P15-P18) (Figs. 3D-F, 5A-C). Muscle biopsies showed mild irregular disorganizations at oxidative staining associated with mild to moderate myopathic changes (Fig. 2D-F) . Few necrotic and regenerative fibers, as well as RVs in sparse fibers were evident in P17. By EM, we showed the presence of small and focal areas involving one sarcomere as clear areas with loss of myofilaments including M-line dissolution with almost intact Z-line (P15) (Fig. 5A) , Z-line diffusion spanning all along the sarcomere (Fig. 5B) or resembling small "pennants" (P15, P16), or large areas of accumulated dark protein material and myofibrillar striation loss (P15, P16) (Fig. 5C ).
Group 4: HMERF (P19-P23) (Figs. 5D-F, 6 ). All biopsies showed internalized nuclei (Fig. 6A) , and numerous fuchsinophilic inclusions corresponding to CBs, presenting a remarkable circular disposition in some fibers in P19 and P21 (Fig. 6B-D) . By EM some CBs showed small electron dense 
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Titinopathies: Ultrastructural Particularities amorphous inclusions among the thin filaments in the peripheral halo (P19 and P21) (Fig. 5D, E) . Widespread abnormal areas corresponding to accumulated filamentous material and damage of myofibrils with loss of striations were frequently observed (P19, P21, P23). Furthermore, we rarely found focal sarcomere disruptions with small "pennants" starting from the Z-line (P19, P23). Eventually, we encountered some atrophic fibers with completely disorganized internal structure and rods (P19), and rimmed/autophagic vacuoles (P19, P21, P23) (Fig. 5F ).
Summary
Overall, Group 1 (AR-CM) was characterized by multiple and small particular areas of sarcomere disorganization distributed through the muscle fibers. In AR-ED and AR-DM, sarcomere disruptions were associated with mild myopathic changes or moderate dystrophic pattern 6 RVs. In HMERF patients, CBs were the main feature, with a typical but not constant circular peripheral distribution.
As a whole, in all muscle biopsies we identified variable sarcomere disruptions suggesting a loss of sarcomeric scaffolding as common histopathologic lesions associated with TTN pathogenic mutations.
DISCUSSION
TTN-related myopathies comprise a large group of different clinical entities (24) (25) (26) . The relatively recent employment of NGS techniques has led and probably will continue to lead to increased numbers of genetic variants described in TTN as well as new associated clinical phenotypes (28, 38, 43, 44) . Our study focuses on the description of recessive TTN cases and HMERF cases. Interestingly, while HMERF is usually a dominant disorder, P22 presented with homozygous p.Pro31732Leu mutation. This mutation (initially described as p.Pro30091Leu) was reported by Palmio et al in 2014 as a semirecessive mutation since some heterozygous carriers don't develop a disease and some do (37) . An outstanding diagnostic challenge is the assignment of a pathogenic value to the already huge and still increasing number of TTN sequence variants identified with NGS (27) . Moreover, reliable functional tests for the interpretation of single variants are lacking. However, considering the high number of variants of uncertain significance in the TTN gene, confrontation of molecular, clinical and morphological data is crucial for the establishment of the molecular diagnosis.
With the morphological studies of 23 TTN mutated patients, we intended to correlate specific histopathological lesions with each different clinical group of patients. AR-CM patients (P1-P10) from Group 1 presented a typical congenital myopathy phenotype (Table 1) . Cardiomyopathy was present in 2 cases (P7 and P8) and was reported in a clinically affected sister of P2. All patients harbored recessive compound heterozygous mutations in different exons of TTN involving different domains but predominantly located in the A-band. Muscle biopsies showed disorganizations of the mesh of the intermyofibrillar network at oxidative staining as predominant findings, associated with type 1 fiber predominance, internalized or centralized nuclei, corresponding to some extent to previously described pathological spectrum of the disorder (28, 36, 37) . Nevertheless, ultrastructural studies (Table 2) consistently revealed common and relevant features: (1) small clear areas of focal myofibrillar disintegration with loss of thick filament corresponding to dissolution of M-band structure, and sometimes also A-band, with almost intact Z-line (Figs. 2A, B, 7A, B) ; (2) areas with Z-line diffusion spanning all along the sarcomere, or resembling small "pennants" (Fig. 2C, D, F) ; and (3) focal myofibrillar disorganizations with Z-line streaming and paucity of mitochondria, involving a few sarcomeres (Fig. 2E) .
Patients from Group 2 with AR-ED (P11-P14) harbored compound heterozygous (P12, P13, P14) or homozygous (P11) mutations involving M-line protein domains. Muscle biopsies had a variably severe dystrophic pattern with RVs, rods and CBs. Our detailed ultrastructural analysis allowed disclosing the presence of distinctive small and focal areas of sarcomere disorganizations with M-line dissolution in all patients (Fig. 4A, B) . Some of CBs had an atypical aspect with small dense material in the peripheral halo (Table 2) .
Group 3 patients P15 and P16 were originally considered as severe early-onset TMD with proximal involvement (39) , and shared a mutation in exon 363/Mex5 but harbored different second truncating mutations that explained their more severe phenotype (39-41) allowing them to be redefined as AR-DM. P17 and P18 harbored the same 2 mutations in exons 364/Mex6 and 274. Muscle biopsies revealed multiple nuclear internalization and uneven oxidative staining. Mild variability in the size of the fibers, slight increase in endomysial connective tissue and some RVs were evident in P17. EM mainly showed both focal and large areas of disorganizations with myofibrillar/filaments loss (Fig. 5A-C ) (P15 and P16).
Group 4 included HMERF patients (P19-P23) characterized by severe early respiratory insufficiency with variable degree of muscular involvement. P19 showed uncommon early-onset at 10 years old. All the patients harbored missense TTN mutations in the same TTN exon 344 (35) . Presence of CBs was the common and most prominent histological feature (Fig. 6 ). CBs were preferentially subsarcolemmal, sometimes with a circular peripheral distribution of CBs as described (45) . EM disclosed that some of them harbored the presence of short segments of dense material in the peripheral halo (Fig. 5D, E) . Variable length of sarcomere disorganizations has also been reported in biopsies from HMERF patients (34, (45) (46) (47) . Our cases showed mainly large areas of protein material deposit (P19, P21, P23) and Z-line streaming Titinopathies: Ultrastructural Particularities resembling small "pennants" (P19, P23). Atrophic fibers showed complete sarcomere disorganization, rods and rimmed/autophagic vacuoles (P19, P21). As a whole, we identified here that TTN pathogenic mutations cause a large spectrum of histopathologic lesions always associated with particular sarcomere disruptions. Although one could imagine that the presence of sarcomeric pathology is as an expected finding related to the loss of titin intrinsic properties, the above mentioned particular sarcomeric disruption presented common elements such as focal myofibrillar disintegration with loss of thick filament corresponding to dissolution of M-band structure, with almost intact Z-line, that we have never observed in the EM analyses of muscle biopsies from other congenital diseases. The sarcomere disruption observed initially on the band M as shown in Figure 7A -D, then in Figures 2B and 5A , can be extended later on the whole of the sarcomere structure, as shown in Figures 2A and  4A . The dissolution of M line with almost intact Z line could be considered as an early lesion (Fig. 7) and, clearly, there may be different degrees of disruption of the sarcomere. Thus, these lesions might be considered as a common and priming myofibril damage that successively lead to the development of multiple and variable histopathological alterations.
Of note, these restricted and focal sarcomere abnormalities identified in TTN-related myopathies appear different from classical cores or minicores lesions as observed in myopathies related to RYR1 (OMIM *180901) and SEPN1 (OMIM *606210) genes. Indeed, ultrastructurally, typical cores found in RYR1 mutated patients correspond to wide areas of compacted and disorganized myofibrils, with Z-line streaming and absence of mitochondria extending over numerous sarcomeres or almost along the full length of the fibers; they are sharply demarcated from the normally structured zones of the muscle fibers (48) . However, mostly in RYR1 recessives, the core areas frequently occupied the whole myofiber cross sectional and extended to a moderate number of sarcomeres in length (49) . In contrast, the classical minicores as found in SEPN1-related myopathies have poorly defined borders and are characterized by the presence of multiple foci of myofilamentary disorganization, with Z-line streaming running over a few sarcomeres, even if occasionally they are longer; mitochondria are absent from the altered areas (48) . Additionally, and this is a key point in our work, these "minicore" lesions never appear as focal clear areas of myofibrillar disruption involving one or few sarcomeres, with M-line disintegration and some loss of filaments in the central part of the abnormal areas associating with almost intact Z-line, as we observed in TTN-related myopathies (Figs. 2A, B, 4A , B, 5A). On the basis of our findings, we aimed at establish a strong correlation between histopathologic phenotype and genotype that would explain the mechanism underlying the loss of sarcomere scaffolding. Unfortunately, this was hindered by the lack of tools for functional studies of the mutations. Further studies will also be required to better characterize the TTN isoforms and their role for muscle function.
In conclusion, our morphological analysis of the muscle biopsies from 23 patients carrying TTN pathogenic mutations suggest a recognizable pattern of myofibrillar alteration that could help in the diagnosis of titinopathies in a complicated scenario where functional studies are still lacking. Further histopathological analyses are needed to assess the exact specificity of these lesions.
